Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09669 | 31652761 | Nutrients | Obesity in the Liver Transplant Setting. | 2019 | Details |
| A09670 | 31652636 | Cells | MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. | 2019 | Details |
| A09671 | 31652578 | Int J Mol Sci | The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma. | 2019 | Details |
| A09672 | 31652524 | Animals (Basel) | The Anti-Oxidation and Mechanism of Essential Oil of Paederia scandens in the NAFLD Model of Chicken. | 2019 | Details |
| A09673 | 31652512 | Nutrients | The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial. | 2019 | Details |
| A09674 | 31652406 | Can J Physiol Pharmacol | The pharmacokinetics of mycophenolic acid in rats with orotic acid induced nonalcoholic fatty liver disease. | 2019 | Details |
| A09675 | 31651873 | Medicine (Baltimore) | Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: A cross-sectional study. | 2019 | Details |
| A09676 | 31651666 | J Pediatr Gastroenterol Nutr | Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. | 2020 | Details |
| A09677 | 31651653 | Eur J Gastroenterol Hepatol | The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study. | 2020 | Details |
| A09678 | 31651649 | Eur J Gastroenterol Hepatol | Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink. | 2020 | Details |
| A09679 | 31651571 | J Clin Gastroenterol | The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A09680 | 31651429 | AIDS | Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. | 2020 | Details |
| A09681 | 31650383 | Mol Biol Rep | High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes. | 2019 | Details |
| A09683 | 31650134 | Food Funct | Regulation effects of rosemary (Rosmarinus officinalis Linn.) on hepatic lipid metabolism in OA induced NAFLD rats. | 2019 | Details |
| A09685 | 31649787 | Prz Gastroenterol | Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study. | 2019 | Details |
| A09686 | 31648561 | FASEB J | KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-κB-FGF21 or SREBP1c-FGF21 pathway. | 2019 | Details |
| A09687 | 31647808 | PLoS Genet | Causal relationships between obesity and the leading causes of death in women and men. | 2019 | Details |
| A09688 | 31647137 | J Ultrasound Med | Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population. | 2019 | Details |
| A09689 | 31646850 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians. | 2019 | Details |
| A09690 | 31646583 | Eur Rev Med Pharmacol Sci | Key molecular pathways in the progression of non-alcoholic steatohepatitis. | 2019 | Details |
| A09691 | 31645988 | BMJ Open Gastroenterol | Relationship between Streptococcus mutans expressing Cnm in the oral cavity and non-alcoholic steatohepatitis: a pilot study. | 2019 | Details |
| A09692 | 31645727 | Nature | Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. | 2019 | Details |
| A09693 | 31645659 | Acta Pharmacol Sin | WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice. | 2019 | Details |
| A09694 | 31645151 | Expert Rev Gastroenterol Hepatol | From circadian clocks to non-alcoholic fatty liver disease. | 2019 | Details |
| A09695 | 31644993 | J Neurol Sci | Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. | 2019 | Details |
| A09696 | 31643035 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? | 2019 | Details |
| A09697 | 31642599 | HIV Med | Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients. | 2019 | Details |
| A09698 | 31641351 | Int J Endocrinol | RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09699 | 31641249 | Nat Rev Gastroenterol Hepatol | Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. | 2019 | Details |
| A09700 | 31640966 | Nan Fang Yi Ke Da Xue Xue Bao | [Correlation between serum 25(OH) vitamin D and liver fat content in nonalcoholic fatty liver disease]. | 2019 | Details |
| A09701 | 31640183 | Nutrients | Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09702 | 31639005 | Lipids Health Dis | Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. | 2019 | Details |
| A09703 | 31638854 | Am J Physiol Endocrinol Metab | Transcription profiling in the liver of undernourished male rat offspring reveals altered lipid metabolism pathways and predisposition to hepatic steatosis. | 2019 | Details |
| A09704 | 31638518 | Am Surg | One Hundred Fifty Liver Transplants at a New Program in the Modern Era: The University of Mississippi Experience. | 2019 | Details |
| A09705 | 31638270 | Clin Pharmacol Ther | Acetaminophen-Induced Liver Damage in Hepatic Steatosis. | 2019 | Details |
| A09706 | 31638173 | Int J Mol Med | Role and mechanisms of action of microRNA‑21 as regards the regulation of the WNT/β‑catenin signaling pathway in the pathogenesis of non‑alcoholic fatty liver disease. | 2019 | Details |
| A09707 | 31638172 | Int J Mol Med | The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice. | 2019 | Details |
| A09708 | 31637675 | J Endocrinol Invest | High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. | 2019 | Details |
| A09709 | 31637670 | Obes Surg | What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)? | 2020 | Details |
| A09710 | 31637346 | J Endocr Soc | Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics. | 2019 | Details |
| A09711 | 31637181 | J Transl Int Med | Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient. | 2019 | Details |
| A09712 | 31636851 | Toxicol Res | Theracurmin (Highly Bioavailable Curcumin) Prevents High Fat Diet-Induced Hepatic Steatosis Development in Mice. | 2019 | Details |
| A09713 | 31635470 | Vnitr Lek | Liver transplantation - changes in indications over last decade. | 2019 | Details |
| A09714 | 31635469 | Vnitr Lek | Serum markers in diagnostics of steatohepatitis. | 2019 | Details |
| A09715 | 31635468 | Vnitr Lek | Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09716 | 31635436 | Cells | Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A09717 | 31635053 | Cells | Magnetic-Assisted Treatment of Liver Fibrosis. | 2019 | Details |
| A09718 | 31634861 | Top Antivir Med | HIV and the liver. | 2019 | Details |
| A09719 | 31634581 | Clin Gastroenterol Hepatol | Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched Controls. | 2019 | Details |
| A09720 | 31634532 | J Hepatol | Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis. | 2019 | Details |
| A09721 | 31634357 | PLoS One | Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver. | 2019 | Details |
| A09722 | 31634046 | J Med Food | Oral Administration of Hoodia parviflora Alleviates Insulin Resistance and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09723 | 31633724 | Arq Gastroenterol | A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA. | 2019 | Details |
| A09724 | 31633721 | Arq Gastroenterol | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS. | 2019 | Details |
| A09726 | 31633654 | J Pediatr Gastroenterol Nutr | Evaluation of Quantitative Imaging Biomarkers for Early-phase Clinical Trials of Steatohepatitis in Adolescents. | 2020 | Details |
| A09727 | 31633048 | JGH Open | Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis. | 2019 | Details |
| A09728 | 31632961 | Front Cell Dev Biol | NFκB/Orai1 Facilitates Endoplasmic Reticulum Stress by Oxidative Stress in the Pathogenesis of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09729 | 31632666 | Biomed Rep | Comparison of the effect of light alcohol consumption on Japanese men with and without fatty liver. | 2019 | Details |
| A09730 | 31632525 | Am J Transl Res | Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling. | 2019 | Details |
| A09731 | 31632457 | Therap Adv Gastroenterol | Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction. | 2019 | Details |
| A09732 | 31632452 | Nutr Metab (Lond) | Hepatic PKA inhibition accelerates the lipid accumulation in liver. | 2019 | Details |
| A09733 | 31632274 | Front Pharmacol | Protective Effect of Patchouli Alcohol Against High-Fat Diet Induced Hepatic Steatosis by Alleviating Endoplasmic Reticulum Stress and Regulating VLDL Metabolism in Rats. | 2019 | Details |
| A09734 | 31632109 | Diabetes Metab Syndr Obes | Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model. | 2019 | Details |
| A09735 | 31631714 | Curr Med Res Opin | Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges. | 2019 | Details |
| A09736 | 31631098 | Endocr J | Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status. | 2019 | Details |
| A09737 | 31630912 | Surg Oncol | Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium. | 2019 | Details |
| A09738 | 31630897 | Trends Endocrinol Metab | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | 2019 | Details |
| A09739 | 31630534 | Am J Physiol Gastrointest Liver Physiol | Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. | 2019 | Details |
| A09740 | 31630414 | Hepatology | Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities. | 2020 | Details |
| A09741 | 31630405 | Clin Pharmacol Ther | Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09742 | 31629472 | Biochem Biophys Res Commun | MC4R deficiency in pigs results in hyperphagia and ultimately hepatic steatosis without high-fat diet. | 2019 | Details |
| A09743 | 31629366 | Endocr Rev | Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. | 2020 | Details |
| A09744 | 31628998 | Clin Gastroenterol Hepatol | Decreased Physical Working Capacity in Adolescents With Nonalcoholic Fatty Liver Disease Associates With Reduced Iron Availability. | 2019 | Details |
| A09746 | 31628409 | Sci Rep | Accuracy of proton magnetic resonance for diagnosing non-alcoholic steatohepatitis: a meta-analysis. | 2019 | Details |
| A09747 | 31628070 | Ann Hepatol | The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. | 2019 | Details |
| A09748 | 31627351 | Medicina (Kaunas) | Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease-A Cross Sectional Study. | 2019 | Details |
| A09749 | 31627243 | Liver Int | Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. | 2019 | Details |
| A09750 | 31626206 | Arkh Patol | [Evaluation of the effect of remaxol on hepatocytes in non-alcoholic fatty liver dystrophy modeling in laboratory C57BL/6 mice]. | 2019 | Details |
| A09751 | 31625959 | Eur J Gastroenterol Hepatol | Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. | 2020 | Details |
| A09752 | 31625373 | Clin Lab | Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A09754 | 31623368 | Nutrients | Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. | 2019 | Details |
| A09755 | 31623280 | Metabolites | Mitochondrial Dysfunction in the Transition from NASH to HCC. | 2019 | Details |
| A09756 | 31622986 | Exp Clin Endocrinol Diabetes | Exogenous Hydrogen Sulfide Alleviates-Induced Intracellular Inflammation in HepG2 Cells. | 2019 | Details |
| A09757 | 31622696 | J Hepatol | The gut-liver axis in liver disease: Pathophysiological basis for therapy. | 2019 | Details |
| A09758 | 31622581 | Am J Med | Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09759 | 31622202 | Curr Drug Deliv | Protective Effects of Incretin Against Age-Related Diseases. | 2019 | Details |
| A09760 | 31621579 | Elife | Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. | 2019 | Details |
| A09761 | 31620652 | Transl Gastroenterol Hepatol | Effect of alcohol consumption on nonalcoholic fatty liver disease. | 2019 | Details |
| A09762 | 31620647 | Transl Gastroenterol Hepatol | Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. | 2019 | Details |
| A09763 | 31620616 | Yeungnam Univ J Med | Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology. | 2019 | Details |
| A09764 | 31619310 | Br J Nutr | Association between edible mushroom intake and the prevalence of newly diagnosed non-alcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health Cohort Study in China. | 2020 | Details |
| A09765 | 31619023 | Cells | Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09766 | 31618976 | Int J Mol Sci | The Potential of the FSP1cre-Pparb/d-/- Mouse Model for Studying Juvenile NAFLD. | 2019 | Details |
| A09767 | 31618396 | Arq Gastroenterol | SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE. | 2020 | Details |
| A09768 | 31617224 | Aliment Pharmacol Ther | Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres. | 2019 | Details |
| A09769 | 31617130 | Dig Dis Sci | Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference. | 2019 | Details |
| A09770 | 31616668 | Front Med (Lausanne) | Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review. | 2019 | Details |
| A09771 | 31616384 | Front Endocrinol (Lausanne) | Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09772 | 31615498 | BMC Endocr Disord | Elevated serum levels of aminotransferases in relation to unhealthy foods intake: Tehran lipid and glucose study. | 2019 | Details |
| A09774 | 31614690 | Int J Mol Sci | Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. | 2019 | Details |